Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer

Author:                  

Publisher: Spandidos Publications

ISSN: 1107-3756

Source: International Journal of Molecular Medicine, Vol.33, Iss.6, 2014-01, pp. : 1514-1522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next